Literature DB >> 4935640

Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.

Z Laron, A Pertzelan, M Karp, A Kowadlo-Silbergeld, W H Daughaday.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4935640     DOI： 10.1210/jcem-33-2-332

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  29 in total

1.  Familial growth hormone insensitivity syndrome.

Authors:  A H Zargar; B A Laway; S R Masoodi; M Salahuddin; M A Siddiqui
Journal:  Indian J Pediatr       Date:  1995 Mar-Apr       Impact factor: 1.967

2.  Familial growth hormone insensitivity syndrome.

Authors:  A H Zargar; B A Laway; S R Masoodi; M Salahuddin; M A Siddiqui
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 3.  Growth hormone insensitivity (Laron syndrome).

Authors:  Zvi Laron
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 4.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 5.  Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.

Authors:  Z Laron
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Identification of two novel mutations in the human growth hormone receptor gene.

Authors:  O Shevah; P Borrelli; M Rubinstein; Z Laron
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

7.  Raised somatomedin associated with normal growth hormone. A cause of Beckwith-Wiedemann syndrome?

Authors:  G S Spencer; F Schabel; H Frisch
Journal:  Arch Dis Child       Date:  1980-02       Impact factor: 3.791

8.  Renal function in Laron syndrome patients treated by insulin-like growth factor-I.

Authors:  B Klinger; Z Laron
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

9.  Puberty in Laron type dwarfism.

Authors:  Z Laron; R Sarel; A Pertzelan
Journal:  Eur J Pediatr       Date:  1980-06       Impact factor: 3.183

10.  Growth curves for Laron syndrome.

Authors:  Z Laron; P Lilos; B Klinger
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.